Victory Capital Management
VRCA icon

Victory Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Victory Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-174
Closed -$19K – 3279
2020
Q1 		$19K Buy
+174
New +$22.9K ﹤0.01% 2862
2019
Q4 		– Sell
-134
Closed -$20K – 3274
2019
Q3 		$20K Buy
+134
New +$14.9K ﹤0.01% 3052

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Victory Capital Management's VRCA Position: Q2 2020 in Review

Victory Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q2 2020, closing a stake of 174 shares — an estimated $19K sold.

Victory Capital Management first reported a position in VRCA in Q3 2019 and held it in 2 quarters. The position peaked at $20K in Q3 2019. 48 funds tracked by Wall St. Rank hold VRCA as of Q2 2020.

  • Victory Capital Management reported no remaining Verrica Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 174 Verrica Pharmaceuticals shares in Q2 2020, an estimated $19K.
  • Victory Capital Management first reported a position in Verrica Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Verrica Pharmaceuticals position peaked at $20K in Q3 2019.
  • 48 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.